Global Pulmonary drug delivery devices market was valued at US $35.6 Bn in 2022 and is expected to reach US $48.5 Bn by 2030, growing at a CAGR of 5% during the forecast period 2023-2030. The Pulmonary Drug Delivery Devices market has witnessed significant growth in recent years, driven by a surge in respiratory disorders and the increasing adoption of advanced therapeutic solutions. Healthcare...